In 2023, Germany's import of insulin in dosage forms stood at approximately 2.750 million kilograms. Forecasted data suggests a steady growth from 2024 to 2028, beginning at 2.7861 million kilograms in 2024 and rising to 2.9281 million kilograms by 2028. The year-on-year growth rates indicate small but consistent increases, signaling stable demand for insulin imports due to growing healthcare needs. The compound annual growth rate (CAGR) over this period reflects this stable upward trend.
Future trends to watch include technological advances in diabetes management, which might affect insulin demand. Additionally, policy changes in healthcare and pharmaceutical sectors could impact import volumes.
